TrialClinical drug investigation2011
Effect of Ipragliflozin (ASP1941), a novel selective sodium-dependent glucose co-transporter 2 inhibitor, on urinary glucose excretion in healthy subjects.
Stephan A Veltkamp et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it